Vijay Shanker

Vijay Shanker is an experienced professional in the fields of biochemistry and drug discovery, currently serving as a Business Partner at Rubix108 Technologies since September 2017. Previously, Vijay held roles as a Postdoctoral Scientist at the University of Basel, where work focused on PROTACs synthesis, multi-target drug development, and molecular biology management, and at Memo Therapeutics AG/ETH Zurich, specializing in high-throughput therapeutic antibody characterization. Vijay earned a PhD in Biochemistry from the University of Basel, with research concentrated on viral hepatitis, innate immunity, and peptide nanoparticle development. Earlier professional experiences include project assistance at the National Institute of Immunology, research at the University of Hyderabad, and significant laboratory management expertise.